Click image to enlarge
U-PLEX Combos offer popular panels of biomarkers that have been grouped together for convenient ordering. They have been tested for multiplex compatibility and are fulfilled as a kit. The U-PLEX Chemokine Combo (mouse) contains assays for 7 well-established chemokines (Table 1). The assays can be used for quantitative measurements in the sample types listed in the "Specifications" tab below, and offer detection limits (LLODs) in the sub- to low pg/mL range.
| Analyte |
LLOD - ULOD |
units |
| IP-10 |
0.50 - 4,900 |
pg/mL |
| KC/GRO |
0.43 - 2,400 |
pg/mL |
| MCP-1 |
1.4 - 1,400 |
pg/mL |
| MIP-1α |
0.21 - 2,100 |
pg/mL |
| MIP-1β |
13 - 30,800 |
pg/mL |
| MIP-2 |
0.30 - 2,000 |
pg/mL |
| MIP-3α |
0.10 - 2,500 |
pg/mL |
-
Specifications
-
-
Kit Contents
-
Documentation
-
References
|
Application(s)
|
|
Cytokines & Chemokines
,
Immunology/Inflammation
|
|
|
Analyte(s)
|
|
IP-10, KC/GRO, MCP-1, MIP-1α, MIP-1β, MIP-2, MIP-3α
|
|
|
Species
|
|
Mouse
|
|
|
Instrument(s)
|
|
SECTOR Imager 2400
,
MESO SECTOR S 600MM
,
SECTOR Imager 6000
,
MESO QuickPlex SQ 120MM
,
MESO QuickPlex SQ 120
,
MESO SECTOR S 600
|
|
|
U-PLEX Group Compatibility
|
|
Biomarker Group 1
|
|
|
Plate Type
|
|
96-well
|
|
|
Sample Type
|
|
Serum, Plasma, Cell Culture Supernatant
|
|
|
Usage Statement
|
|
For Research Use Only. Not for use in diagnostic procedures.
|
|
|
Storage Statement(s)
|
|
Please refer to the product insert for the storage conditions of individual kit components.
|
|
|
Storage Condition
|
|
Multi-Component
|
|
|
Schedule B Code
|
|
3822.19.0000
|
|
|
Product Description
|
Storage
|
Quantity per Kit
|
|
U-PLEX Linker Set, 7-Assay (300 µL)
|
2-8 °C
|
1 each
(1 vial)
|
|
|
|
|
2-8 °C
|
1 each
(1 plate size)
|
|
|
|
|
2-8 °C
|
1 each
(1 plate size)
|
|
|
|
|
2-8 °C
|
1 each
(1 plate size)
|
|
|
|
|
2-8 °C
|
1 each
(1 plate size)
|
|
|
|
|
2-8 °C
|
1 each
(1 plate size)
|
|
|
|
|
2-8 °C
|
1 each
(1 plate size)
|
|
|
|
|
2-8 °C
|
1 each
(1 plate size)
|
|
|
|
|
2-8 °C
|
1 vial
(1 vial)
|
|
|
|
|
2-8 °C
|
1 vial
(1 vial)
|
|
|
|
U-PLEX 7-Assay, 96-Well SECTOR Plate
|
2-8 °C
|
1 each
(1 plate)
|
|
|
|
|
≤-10 °C
|
1 bottle
(10 mL)
|
|
|
|
|
≤-10 °C
|
1 bottle
(8 mL)
|
|
|
|
U-PLEX Stop Solution
|
2-8 °C
|
1 bottle
(40 mL)
|
|
|
|
|
RT
|
1 bottle
(18 mL)
|
|
|
|
Product Description
|
Storage
|
Quantity per Kit
|
|
U-PLEX Linker Set, 7-Assay (1.8 mL)
|
2-8 °C
|
1 each
(1 vial)
|
|
|
|
|
2-8 °C
|
1 each
(5 plate size)
|
|
|
|
|
2-8 °C
|
1 each
(5 plate size)
|
|
|
|
|
2-8 °C
|
1 each
(5 plate size)
|
|
|
|
|
2-8 °C
|
1 each
(5 plate size)
|
|
|
|
|
2-8 °C
|
1 each
(5 plate size)
|
|
|
|
|
2-8 °C
|
1 each
(5 plate size)
|
|
|
|
|
2-8 °C
|
1 each
(5 plate size)
|
|
|
|
|
2-8 °C
|
5 vial
(1 vial)
|
|
|
|
|
2-8 °C
|
5 vial
(1 vial)
|
|
|
|
U-PLEX 7-Assay, 96-Well SECTOR Plate
|
2-8 °C
|
5 each
(1 plate)
|
|
|
|
|
≤-10 °C
|
1 bottle
(50 mL)
|
|
|
|
|
≤-10 °C
|
1 bottle
(40 mL)
|
|
|
|
U-PLEX Stop Solution
|
2-8 °C
|
1 bottle
(40 mL)
|
|
|
|
|
RT
|
1 bottle
(90 mL)
|
|
|
|
Product Description
|
Storage
|
Quantity per Kit
|
|
U-PLEX Linker Set, 7-Assay (1.8 mL)
|
2-8 °C
|
5 each
(1 vial)
|
|
|
|
|
2-8 °C
|
5 each
(5 plate size)
|
|
|
|
|
2-8 °C
|
5 each
(5 plate size)
|
|
|
|
|
2-8 °C
|
5 each
(5 plate size)
|
|
|
|
|
2-8 °C
|
5 each
(5 plate size)
|
|
|
|
|
2-8 °C
|
5 each
(5 plate size)
|
|
|
|
|
2-8 °C
|
5 each
(5 plate size)
|
|
|
|
|
2-8 °C
|
5 each
(5 plate size)
|
|
|
|
|
2-8 °C
|
25 vial
(1 vial)
|
|
|
|
|
2-8 °C
|
25 vial
(1 vial)
|
|
|
|
U-PLEX 7-Assay, 96-Well SECTOR Plate
|
2-8 °C
|
25 each
(1 plate)
|
|
|
|
|
≤-10 °C
|
5 bottle
(50 mL)
|
|
|
|
|
≤-10 °C
|
5 bottle
(40 mL)
|
|
|
|
U-PLEX Stop Solution
|
2-8 °C
|
5 bottle
(40 mL)
|
|
|
|
|
RT
|
5 bottle
(90 mL)
|
|
|
|
Product Inserts
|
|
|
|
Datasheets
|
|
|
|
SDS
|
|
|
|
Title
|
Journal
|
Year
|
|
Galectin-9, a Player in Cytokine Release Syndrome and a Surrogate Diagnostic Biomarker in SARS-CoV-2 Infection
|
|
|
|
The inflammatory profile of cerebrospinal fluid, plasma, and saliva from patients with severe neuropathic pain and healthy controls-a pilot study
|
|
|
|
Anti-SARS-CoV-2 IgG from severely ill COVID-19 patients promotes macrophage hyper-inflammatory responses
|
|
|
|
Reliability of self-sampling for accurate assessment of respiratory virus viral and immunologic kinetics
|
|
|
|
Early and late effects of maternal experience on hippocampal neurogenesis, microglia, and the circulating cytokine milieu
|
|
|
|
|
View All
|
Order Details
Catalog No
Size
Price in USD
Qty
Customer Service/Orders
Scientific/Technical Support
Instrument Support
Company Headquarters